Rockwell Medical, Inc (RMTI)
Rockwell Medical is a commercial-stage, biopharmaceutical company developing and commercializing its parenteral iron technology platform, Ferric Pyrophosphate Citrate (FPC). Co. is also a supplier of hemodialysis concentrate products to kidney dialysis clinics in the U.S. Co. has two therapies, Triferic and Triferic AVNU, which are developed from its FPC platform. Co. markets both products to kidney dialysis centers for their patients receiving dialysis. Co. has filed an Investigational New Drug Application to conduct a Phase II trial for the treatment of iron deficiency anemia in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting.
| Company Name: |
Rockwell Medical, Inc |
| Website: |
www.rockwellmed.com |
| Sector: |
Drugs & Pharmaceuticals |
| Number of ETFs Holding RMTI: |
3 |
| Total Market Value Held by ETFs: |
$1.68M |
| Total Market Capitalization: |
$44.00M |
| % of Market Cap. Held by ETFs: |
3.82% |
|
|
April 18, 2024 • 6:35 PM Eastern
Strong Buy (4.00 out of 4)
100th percentile
|
|
Free RMTI Email Alerts:
